BIORELIANCE CORPORATION
Doing business as BIORELIANCE CORP DE
- ROCKVILLE, MD 20850-3304
- sigmaaldrich.com (company website, opens in a new tab)
- Corporate Entity (Not Tax Exempt)
- SAM active
- No verified credentials yet
- CMMCNot on file
- SPRSNone
- FCLVisible to paid members
Registration and small-business types: SAM.gov, synced Nov 9, 2026. Compliance: self-attested by the company unless marked verified. The SPRS chip shows a range, never the exact score. How verification works
- 36-mo obligations
- $1.2M
- Awards on record
- 9
- Contract vehicles
- 0
- Verified credentials
- 0
Compliance posture: unverified (SAM.gov baseline only)
BIORELIANCE CORPORATION has not claimed this profile. What you see comes from public SAM.gov and USAspending records; no one from the company has confirmed CMMC, SPRS or clearance details yet. Learn more about CMMC 2.0
About BIORELIANCE CORPORATION
- Headquarters
- ROCKVILLE, MD 20850-3304
Identifiers
UEI and CAGE come from SAM.gov. Other identifiers are listed by the company.
- UEIH3KAG9A26K77
- CAGE1CPE3
Capabilities & differentiators
No capability narrative yet
Compliance posture
No compliance posture published yet
Facility clearance
Facility clearance: visible to paid members
Clearance levels are shown only to paying members; TeamingIndex does not advertise clearances (NISPOM 32 CFR 117.9). Learn more about facility clearances · Compare plans
Past performance
- 36-month obligations
- $1.2M
- Awards on record
- 9
- Top funding agencies
- Centers for Disease Control and Prevention · National Institutes of Health
Awards
75D30126P21070
Recompete 6–12 mo: Potential end May 31, 2027 (6 months away)CRYOGENIC STORAGE OF CGMP GRADE CELL BANKS-EO 14398
Department of Health and Human Services · Centers for Disease Control and Prevention
- Obligated
- $41.3K
- Period of performance
- Jun 1, 2026 – May 31, 2027
75D30124P19870
Completed: Period of performance ended Sep 24, 2026FOLLOW-UP TESTING FOR TUMORIGENICITY AND ONCOGENICITY.
Department of Health and Human Services · Centers for Disease Control and Prevention
- Obligated
- $248.8K
- Period of performance
- Sep 26, 2024 – Sep 24, 2026
75D30121C10819
Completed: Period of performance ended Jul 15, 2026BIORELIANCE EXPI293F
Department of Health and Human Services · Centers for Disease Control and Prevention
- Obligated
- $670.3K
- Period of performance
- Jul 16, 2021 – Jul 15, 2026
75D30121P10233
Completed: Period of performance ended May 31, 2026STORAGE RENEWAL FOR CDC VERO AND MDCK CELLS
Department of Health and Human Services · Centers for Disease Control and Prevention
- Obligated
- $131.2K
- Period of performance
- Jan 22, 2021 – May 31, 2026
75N93025P00260
Completed: Period of performance ended Jan 16, 2026BIORELIANCE CORP ENDOTOXIN AND STERILITY TESTING SERVICES
Department of Health and Human Services · National Institutes of Health
- Obligated
- $16.1K
- Period of performance
- Jan 21, 2025 – Jan 16, 2026
75N93024P01101
Completed: Period of performance ended Sep 8, 2025BIORELIANCE CORP ENDOTOXIN AND STERILITY TESTING SERVICES
Department of Health and Human Services · National Institutes of Health
- Obligated
- $15.4K
- Period of performance
- Sep 9, 2024 – Sep 8, 2025
75N93024P00571
Completed: Period of performance ended Aug 30, 2024BIORELIANCE ENDOTOXIN AND STERILITY TESTING
Department of Health and Human Services · National Institutes of Health
- Obligated
- $15.4K
- Period of performance
- Apr 22, 2024 – Aug 30, 2024
75N93024P00543
Completed: Period of performance ended May 15, 2024ENDOTOXIN AND STERILITY TESTING SERVICES
Department of Health and Human Services · National Institutes of Health
- Obligated
- $15.4K
- Period of performance
- Apr 16, 2024 – May 15, 2024
HHSD2002016M90017P
Completed: Period of performance ended May 31, 2020IGF::OT::IGF STORAGE RENEWAL FOR CDC VERO AND MDCK BANKS
Department of Health and Human Services · Centers for Disease Control and Prevention
- Obligated
- $113.2K
- Period of performance
- May 31, 2016 – May 31, 2020
| Award | Agency | NAICS · PSC | Obligated | Period of performance | Recompete |
|---|---|---|---|---|---|
75D30126P21070 CRYOGENIC STORAGE OF CGMP GRADE CELL BANKS-EO 14398 | Department of Health and Human Services · Centers for Disease Control and Prevention | 493120 · AJ13GENERAL SCIENCE & TECHNOLOGY R&D SVCS; GENERAL SCIENCE & TECHNOLOGY; EXPERIMENTAL DEVELOPMENT | $41.3K | Jun 1, 2026 – May 31, 2027 | Recompete 6–12 mo: Potential end May 31, 2027 (6 months away)AI brief for award 75D30126P21070Bid team for the recompete of award 75D30126P21070 |
75D30124P19870 FOLLOW-UP TESTING FOR TUMORIGENICITY AND ONCOGENICITY. | Department of Health and Human Services · Centers for Disease Control and Prevention | 621511 · Q301REFERENCE LABORATORY TESTING | $248.8K | Sep 26, 2024 – Sep 24, 2026 | Completed: Period of performance ended Sep 24, 2026 |
75D30121C10819 BIORELIANCE EXPI293F | Department of Health and Human Services · Centers for Disease Control and Prevention | 541714 · AN12HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH | $670.3K | Jul 16, 2021 – Jul 15, 2026 | Completed: Period of performance ended Jul 15, 2026 |
75D30121P10233 STORAGE RENEWAL FOR CDC VERO AND MDCK CELLS | Department of Health and Human Services · Centers for Disease Control and Prevention | 541380 · Q301REFERENCE LABORATORY TESTING | $131.2K | Jan 22, 2021 – May 31, 2026 | Completed: Period of performance ended May 31, 2026 |
75N93025P00260 BIORELIANCE CORP ENDOTOXIN AND STERILITY TESTING SERVICES | Department of Health and Human Services · National Institutes of Health | 541380 · Q301REFERENCE LABORATORY TESTING | $16.1K | Jan 21, 2025 – Jan 16, 2026 | Completed: Period of performance ended Jan 16, 2026 |
75N93024P01101 BIORELIANCE CORP ENDOTOXIN AND STERILITY TESTING SERVICES | Department of Health and Human Services · National Institutes of Health | 541380 · Q301REFERENCE LABORATORY TESTING | $15.4K | Sep 9, 2024 – Sep 8, 2025 | Completed: Period of performance ended Sep 8, 2025 |
75N93024P00571 BIORELIANCE ENDOTOXIN AND STERILITY TESTING | Department of Health and Human Services · National Institutes of Health | 541380 · B504SPECIAL STUDIES/ANALYSIS- CHEMICAL/BIOLOGICAL | $15.4K | Apr 22, 2024 – Aug 30, 2024 | Completed: Period of performance ended Aug 30, 2024 |
75N93024P00543 ENDOTOXIN AND STERILITY TESTING SERVICES | Department of Health and Human Services · National Institutes of Health | 541380 · Q301REFERENCE LABORATORY TESTING | $15.4K | Apr 16, 2024 – May 15, 2024 | Completed: Period of performance ended May 15, 2024 |
HHSD2002016M90017P IGF::OT::IGF STORAGE RENEWAL FOR CDC VERO AND MDCK BANKS | Department of Health and Human Services · Centers for Disease Control and Prevention | 541990 · L039TECHNICAL REPRESENTATIVE- MATERIALS HANDLING EQUIPMENT | $113.2K | May 31, 2016 – May 31, 2020 | Completed: Period of performance ended May 31, 2020 |
Contract vehicles
No contract vehicles on file
Proven teaming graph
Primes it has worked under
- ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
UEI C8H9CNG1VBD9
$726.9K
Subcontractor to this prime · 1 sub-award · latest Jul 29, 2025
- National Institutes of Health
- “CONDUCT QUALITY CONTROL RELEASE TESTING ON SAMPLES OF TRADITIONAL VACCINES, SPECIFICALLY FOCUSING ON THE FOLLOWING PRODUCTS: NDV MASTER SEED, NDV FINAL PRODUCT, AND NDV BULK HARVEST. PLEASE REFER TO QUOTE NUMBERS R-10151426.1, R-10151430.1, AND R-10151438.1, ATTACHED AND INCORPORATED HEREIN, FOR DETAILED SPECIFICATIONS.”
Subcontractors it has used
No reported sub-awards as a prime contractor.
Source: USAspending.gov sub-award reports (FSRS) (opens in a new tab) · as of Nov 9, 2026 · Prime contractors report first-tier subcontracts of $30,000 or more. Amounts are reported sub-award values.
SBIR/STTR portfolio
SBIR/STTR awardee — Phase III-eligible for work derived from its SBIR/STTR projects
Agencies may award follow-on Phase III work without a new competition when it builds on this company’s earlier SBIR/STTR projects. Other work is competed as usual.
- Awards on record
- 1 award
- Total awarded
- $99,772
- By phase
- SBIR Phase I: 1
- By agency
- Department of Health and Human Services: 1
- By year
- 2001: 1
Awards (most recent first)
SHORT-TERM MOLECULAR CARCINOGENICITY ASSAYS
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2001 · $99,772
Source: SBIR.gov award data file (opens in a new tab) · as of Nov 12, 2026 · file published Nov 1, 2026
FedRAMP offerings
No FedRAMP Marketplace listing
Source: FedRAMP Marketplace (opens in a new tab) · sync date not recorded
Exclusions & screening
SAM.gov exclusions
Not yet checked against SAM.gov exclusions.
Agencies generally may not award to excluded parties, and primes may not subcontract with them above the threshold in FAR 52.209-6 (except COTS items) without a compelling reason reported to the contracting officer (FAR 9.405, 9.405-2). Some exclusion types apply only to specific programs: read the record on SAM.gov.
Source: SAM.gov Exclusions (opens in a new tab) · sync date not recorded
Consolidated Screening List
No confirmed match on the Consolidated Screening List (screened Nov 13, 2026).
The list combines Commerce, State and Treasury export-control and sanctions lists. A “no match” result is a name-and-address screen, not an export-compliance determination.
Source: ITA Consolidated Screening List (opens in a new tab) · as of Nov 13, 2026
GSA CALC+ rate benchmark
No GSA CALC+ rates on record
Source: GSA CALC+ awarded ceiling rates (opens in a new tab) · sync date not recorded
NAICS, PSC & socio-economic status
NAICS codes
- 541714Research and Development in Biotechnology (except Nanobiotechnology)Primary
- 493120Title not in the curated list
- 541380Testing Laboratories and Services
- 541690Other Scientific and Technical Consulting Services
- 541715Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- 541940Title not in the curated list
- 541990All Other Professional, Scientific, and Technical Services
SAM.gov does not report this entity as small under any listed NAICS code.
Socio-economic status
No socio-economic certifications reported in SAM.gov.
Product & service codes (PSC)
- AJ12GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; APPLIED RESEARCH
- AJ13GENERAL SCIENCE & TECHNOLOGY R&D SVCS; GENERAL SCIENCE & TECHNOLOGY; EXPERIMENTAL DEVELOPMENT
- AJ14GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; R&D ADMINISTRATIVE EXPENSES
- AJ15GENERAL SCIENCE & TECHNOLOGY R&D SVCS; GENERAL SCIENCE & TECHNOLOGY; R&D FACILITIES & MAJ EQUIP
- AN12HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH
- AN13HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT
- B528SPECIAL STUDIES/ANALYSIS- REGULATORY
- B529SPECIAL STUDIES/ANALYSIS- SCIENTIFIC DATA
- B599SPECIAL STUDIES/ANALYSIS- OTHER
PSC names from the Acquisition.gov PSC Manual (opens in a new tab) (April 2025 edition), checked Nov 12, 2026.
Teaming preferences
This company has not published teaming preferences.
Business development contact
No BD contact published
Corporate hierarchy
No parent entity reported in SAM.gov.
SBA counts affiliates when it determines whether a business is small (13 CFR 121.103), so a parent’s size can matter for set-aside work.
Data sources & provenance
SAM.gov
Registration, CAGE, NAICS, socio-economic status, corporate hierarchy and exclusions. Last synced Nov 9, 2026.
USAspending.gov
Prime award history and obligations (FPDS), synced nightly.
The contractor
Nothing yet: this profile has not been claimed by the company.
TeamingIndex verification
Credentials marked Verified were checked by a TeamingIndex reviewer; everything else is self-attested.
Corrections
Corrections to SAM.gov data must be made in SAM.gov; TeamingIndex picks them up on the next nightly sync. Go to SAM.gov (opens in a new tab)
Machine-readable: capability.md schema.org JSON-LD embedded in this page.
Zero CUI: TeamingIndex stores verification metadata only, never System Security Plans, POA&Ms or DD Form 254s.
Teaming
Ready to team with BIORELIANCE CORPORATION?
Send an introduction and propose a mutual NDA. Their team is notified right away, and you can share the capability statement with your capture team.
